The role of whole brain radiation in primary CNS lymphoma.
作者信息
Kasenda Benjamin, Loeffler Jay, Illerhaus Gerald, Ferreri Andrés J M, Rubenstein James, Batchelor Tracy T
机构信息
Department of Hematology, Oncology and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany;
Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA;
出版信息
Blood. 2016 Jul 7;128(1):32-6. doi: 10.1182/blood-2016-01-650101. Epub 2016 May 13.
Abstract
摘要
相似文献
1
The role of whole brain radiation in primary CNS lymphoma.
Blood. 2016 Jul 7;128(1):32-6. doi: 10.1182/blood-2016-01-650101. Epub 2016 May 13.
2
Primary central nervous system lymphoma presenting as Parinaud syndrome.
Can J Ophthalmol. 2011 Oct;46(5):445-6. doi: 10.1016/j.jcjo.2011.08.007. Epub 2011 Aug 4.
3
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
Hematol Oncol. 2013 Mar;31(1):10-7. doi: 10.1002/hon.2012. Epub 2012 May 18.
4
Central nervous system vasculitis: all that glitters is not gold.
J Rheumatol. 2012 Mar;39(3):662-3. doi: 10.3899/jrheum.111141.
5
Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.
Am J Hematol. 2010 Aug;85(8):631-3. doi: 10.1002/ajh.21767.
6
Treatment of Early (Limited)-Stage DLBCL.
Clin Lymphoma Myeloma Leuk. 2020 Sep;20 Suppl 1:S34-S36. doi: 10.1016/S2152-2650(20)30454-7.
7
Seesaw nystagmus following whole brain irradiation and intrathecal methotrexate.
J Neuroophthalmol. 2001 Dec;21(4):264-5. doi: 10.1097/00041327-200112000-00007.
8
Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
Can J Neurol Sci. 2002 May;29(2):147-53.
9
Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma.
Lancet Oncol. 2006 Mar;7(3):274. doi: 10.1016/S1470-2045(06)70621-0.
10
[The role of radiotherapy in chemoradiation treatment for nodal diffuse large B-cell non-Hodgkin lymphoma].
Vopr Onkol. 2015;61(1):96-101.
引用本文的文献
1
Efficacy and safety of the R2-MTX regimen in primary central nervous system lymphoma (PCNSL): a single-center retrospective analysis.
J Cancer Res Clin Oncol. 2025 May 22;151(5):173. doi: 10.1007/s00432-025-06205-x.
2
Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101.
Blood Adv. 2024 Jun 25;8(12):3189-3199. doi: 10.1182/bloodadvances.2023011657.
3
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.
BMC Cancer. 2023 Aug 11;23(1):746. doi: 10.1186/s12885-023-11268-5.
4
Primary central nervous system lymphoma.
Nat Rev Dis Primers. 2023 Jun 15;9(1):29. doi: 10.1038/s41572-023-00439-0.
5
Efficacy and toxicity with radiation field designs and concurrent temozolomide for CNS lymphoma.
Neurooncol Pract. 2022 Jun 22;9(6):536-544. doi: 10.1093/nop/npac052. eCollection 2022 Dec.
6
Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
J Hematol Oncol. 2022 Sep 29;15(1):136. doi: 10.1186/s13045-022-01356-7.
7
The Role of Pretherapeutic Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient in Predicting Clinical Outcomes in Immunocompetent Patients with Primary CNS Lymphoma: A Systematic Review and Meta-Analysis.
Asian Pac J Cancer Prev. 2022 Jul 1;23(7):2449-2457. doi: 10.31557/APJCP.2022.23.7.2449.
8
Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting.
Neurooncol Pract. 2022 Jan 12;9(3):183-192. doi: 10.1093/nop/npab066. eCollection 2022 May.
9
Selective salvage radiotherapy could provide favorable outcomes in patients with refractory or relapsed primary central nervous system lymphoma.
J Neurooncol. 2022 Jan;156(2):307-316. doi: 10.1007/s11060-021-03909-1. Epub 2021 Dec 1.
10
Is There an Indication for First Line Radiotherapy in Primary CNS Lymphoma?
Cancers (Basel). 2021 May 25;13(11):2580. doi: 10.3390/cancers13112580.
本文引用的文献
1
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.
2
The role of autologous stem cell transplantation in primary central nervous system lymphoma.
Blood. 2016 Mar 31;127(13):1642-9. doi: 10.1182/blood-2015-10-636340. Epub 2016 Feb 1.
3
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.
Ann Oncol. 2015 Jul;26(7):1305-13. doi: 10.1093/annonc/mdv076. Epub 2015 Feb 20.
4
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
Blood. 2015 Feb 26;125(9):1403-10. doi: 10.1182/blood-2014-10-604561. Epub 2015 Jan 7.
5
The role of additional radiotherapy for primary central nervous system lymphoma.
Cochrane Database Syst Rev. 2014 Jun 16;2014(6):CD009211. doi: 10.1002/14651858.CD009211.pub2.
6
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome.
J Clin Oncol. 2013 Nov 1;31(31):3971-9. doi: 10.1200/JCO.2013.50.4910. Epub 2013 Oct 7.
7
Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma.
Neurology. 2013 Jul 2;81(1):84-92. doi: 10.1212/WNL.0b013e318297eeba. Epub 2013 May 17.
8
Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).
J Clin Oncol. 2013 Sep 1;31(25):3061-8. doi: 10.1200/JCO.2012.46.9957. Epub 2013 Apr 8.
9
Primary CNS lymphoma.
Best Pract Res Clin Haematol. 2012 Mar;25(1):119-30. doi: 10.1016/j.beha.2011.12.001. Epub 2012 Feb 5.
10
Cognitive functions in primary CNS lymphoma after single or combined modality regimens.
Neuro Oncol. 2012 Jan;14(1):101-8. doi: 10.1093/neuonc/nor186. Epub 2011 Oct 19.
Zotero 插件